Related Experiment Video
Updated: Jul 2, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Chondrosarcoma and peroxisome proliferator-activated receptor
K Nishida1, T Kunisada, Z N Shen
1Department of Human Morphology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.
PPARgamma ligands show promise in treating chondrosarcoma by inhibiting cancer cell growth and inducing apoptosis. This targeted therapy offers a novel strategy against malignant cartilage tumors.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands induce differentiation and apoptosis in cancer cells.
- Chondrosarcoma, a malignant cartilage tumor, and the OUMS-27 cell line express PPARgamma.
Purpose of the Study:
- To investigate the therapeutic potential of PPARgamma ligands in chondrosarcoma.
- To elucidate the molecular mechanisms underlying PPARgamma ligand-induced apoptosis and proliferation inhibition in chondrosarcoma cells.
Main Methods:
- Treatment of OUMS-27 cells with PPARgamma ligands, including 15d-PGJ(2).
- Analysis of cell proliferation, apoptosis markers (Bcl-xL, Bax), and cell cycle regulators (p21).
- In vivo assessment of Bcl-xL expression in chondrosarcoma tissues.
Main Results:
- PPARgamma ligands inhibited OUMS-27 cell proliferation in a dose-dependent manner.
- 15d-PGJ(2) downregulated antiapoptotic Bcl-xL and upregulated proapoptotic Bax, inducing caspase-dependent apoptosis.
- 15d-PGJ(2) induced p21 protein expression, contributing to cell proliferation inhibition.
Conclusions:
- Targeted therapy with PPARgamma ligands represents a novel strategy for treating chondrosarcoma.
- PPARgamma ligands effectively inhibit chondrosarcoma cell proliferation and induce apoptosis through modulation of key molecular pathways.
Related Concept Videos
Abnormal Proliferation
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomes
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
